Related Experiment Video

Updated: Jun 4, 2026

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
06:39

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Published on: October 3, 2018

MDM2 and MDMX in cancer and development

Jean-Christophe Marine1

  • 1VIB–K.U.Leuven, Department of Molecular and Developmental Genetics, Laboratory for Molecular Cancer Biology, Leuven, Belgium.

Current Topics in Developmental Biology
|February 8, 2011
PubMed

Insights

The p53 tumor suppressor pathway is normally activated by cellular stress but is often silenced in cancer cells. Tumor cells hijack normal mechanisms, like MDM2 and MDMX proteins, to inhibit p53, offering potential therapeutic targets.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cellular Biology

Background:

  • The p53 tumor suppressor pathway is crucial for cellular response to stress and DNA damage, inducing cell cycle arrest or apoptosis.
  • In normal, unstressed cells and in most tumor cells, p53 activity is tightly regulated or silenced.
  • p53 inactivation in tumors occurs via mutations or other mechanisms affecting its function.

Purpose of the Study:

  • To explore how tumor cells inactivate the p53 pathway.
  • To investigate the role of MDM2 and MDMX proteins in p53 regulation within tumor cells.
  • To discuss the implications for novel cancer therapeutic strategies.

Main Methods:

  • Review of recent biochemical and genetic data.
  • Analysis of aberrant protein expression in tumor cells.
  • Examination of mechanisms restraining p53 function.

Main Results:

  • Tumor cells utilize mechanisms normally employed to restrain p53.
  • Aberrant expression of MDM2 and MDMX proteins is observed in tumor cells.
  • These proteins play a key role in maintaining p53 in an inactive state.

Conclusions:

  • Tumor cells actively suppress p53 function by co-opting normal regulatory pathways.
  • MDM2 and MDMX are critical in enforcing p53 silencing in cancer.
  • Understanding these mechanisms provides a basis for developing new anti-cancer therapies targeting the p53 pathway.

More Related Videos

Identifying Bone Marrow Microenvironmental Populations in Myelodysplastic Syndrome and Acute Myeloid Leukemia06:33

Identifying Bone Marrow Microenvironmental Populations in Myelodysplastic Syndrome and Acute Myeloid Leukemia

Published on: November 10, 2023

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.